Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Oregon House Passes Preemptive Health Reform Bills
The Oregon House of Representatives passed two health reform bills that a leading Democratic lawmakers says will help Oregon "fit into whatever happens on the national scale," the Portland Oregonian reports. One bill would tax insurers and hospitals more than $300 million over two years to provide coverage to an additional 115,000 Oregonians. These funds would "leverage nearly $1 billion in federal Medicaid matching money." The second measure would create an Oregon Health Authority to replace an existing Department of Human Services, but with a broader mandate to track health care claims data and harness consolidated purchasing power to "pressure insurers and hospitals to use evidence based care." State officials say the measure "would create an estimated 3,600 high-paying jobs in hospitals, medical clinics and other areas" (Graves, 6/8).
generic viagra online
UQ Scientist's Outstanding Pain Management Research Recognised
A UQ Science researcher has received a prestigious honorary fellowship for her long-time work into understanding the underlying mechanisms of pain.
News of the day
U.S. Swine Flu Cases Reach One Million
The Associated Press/Washington Post reported that U.S. health officials on Thursday said they believe as many as 1 million Americans have been infected with H1N1 and "6 percent or more of some urban populations are infected." The estimates were based upon survey data collected by health officials and mathematical modeling.
Cardiovascular

Prevalence Of Ureaplasma Urealyticum And Mycoplasma Hominis In Women With Chronic Urinary Symptoms

UroToday.com - Ureaplasma urealyticum and Mycoplasma Hominis are members of a unique group of microorganisms commonly identified in the genital tract of women. With the onset of sexual intercourse the prevalence of Mycoplasma increases dramatically an isolation is strongly dependent on the number of sexual partners. Convincing evidence of an infection caused by genital Mycoplasma is not easy, because they usually are not isolated in pure culture, making the evaluation even more difficult. Dr. Stavroula Baka and colleagues from Athens, Greece evaluated the prevalence of U. urealyticum and M hominis in women presenting with chronic urinary symptoms, and the subsequent improvement, if any, of symptom severity and urinary frequency after appropriate therapy targeting these microorganisms. The 153 patients who completed the study had symptoms including dysuria, pelvic pain, urgency, frequency, and dyspareunia. They had either failed a course of antimicrobial therapy or had negative routine cultures. Urine samples (midstream and catheter specimens), and urethral, vaginal, and cervical swabs were obtained. U. urealyticum was detected from 1 or more sites in 52.9% and M. hominis was detected in 5 women, all of whom were positive for U. urealyticum. In 82.3% of patients positive for U. urealyticum, other pathogens were also identified. A single-dose regimen of 1 gram azithromycin was given to all culture positive patients and recommended for their sexual partner. Those with a positive culture one month after therapy (4.9%) were successfully treated with 7 days of doxycycline 100mg twice daily. Significant improvement was observed in all symptoms. When the mean difference in the urinary symptom scores before and after treatment in women with positive cultures for Mycoplasma only was compared with those from women with Mycoplasma and other organisms as well, dysuria, dyspareunia, urinary urgency, and urinary frequency had improved significantly, while there was no difference in pelvic pain between the groups. The authors conclude that the significant improvement noted in all symptom scores after treatment in women with positive cultures for U. urealyticum and M. hominis suggests that these pathogens might have been involved in the etiology of chronic urinary symptoms experienced in this group of patients. Baka S, Kouskouni E, Antonopoulou S, Sioutis D, Papakonstantinou M, Hassiakos D, Logothetis E, Liapis A Urology. 2009 Jul;74(1):62-6 10.1016/j.urology.2009.02.014 Written by UroToday.com Contributing Editor Philip M. Hanno, MD, MPH UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice. To access the latest urology news releases from UroToday, go to: www.urotoday.com Copyright © 2009 - UroToday


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009